No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long
Guggenheim Initiates Unicycive Therapeutics(UNCY.US) With Buy Rating, Announces Target Price $6
Unicycive Therapeutics Price Target Announced at $6.00/Share by Guggenheim
Benchmark Co. Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Maintains Target Price $3
HC Wainwright & Co. Reiterates Buy on Unicycive Therapeutics, Maintains $7.5 Price Target
Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate
